Literature DB >> 30361338

The Kidney Accelerator: Innovation Wanted, Nephrologists Needed.

Suzanne Watnick1.   

Abstract

Keywords:  chronic kidney disease; dialysis; end stage kidney disease; nephrology; quality of life

Mesh：

Year:  2018        PMID： 30361338      PMCID： PMC6237073          DOI： 10.2215/CJN.04720418

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  5 in total

Review 1.  The number, quality, and coverage of randomized controlled trials in nephrology.

Authors:  Giovanni F M Strippoli; Jonathan C Craig; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

2.  Transforming Nephrology.

Authors:  Mitchell H Rosner; Jeffrey S Berns
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 8.237

3.  Nephrology at a Crossroads.

Authors:  Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 8.237

4.  Addressing Physician Burnout: Nephrologists, How Safe Are We?

Authors:  Amy W Williams
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 8.237

Review 5.  The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov.

Authors:  Jula K Inrig; Robert M Califf; Asba Tasneem; Radha K Vegunta; Christopher Molina; John W Stanifer; Karen Chiswell; Uptal D Patel
Journal:  Am J Kidney Dis       Date:  2013-12-06       Impact factor: 8.860
  5 in total
  3 in total

1.  Role of the Nephro-Hospitalist.

Authors:  Timothy T Yau; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-09       Impact factor: 8.237

2.  Secular Changes in Mortality and Hospitalization over Time in People with Kidney Failure or Severe CKD as Compared with Other Noncommunicable Diseases.

Authors:  Marcello Tonelli; Natasha Wiebe; Matthew T James; Scott W Klarenbach; Braden J Manns; Neesh Pannu; Pietro Ravani; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2020-09-29       Impact factor: 14.978

3.  Advancing American Kidney Health (AAKH): Catalyst for Investment in Kidney Diseases Clinical Trials and Precision Medicine: An Opportunity to Advance Upstream Interventions and the Importance of Nephrology.

Authors:  Kevin John Fowler
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-05       Impact factor: 8.237
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.